The phrase "avoid the drawbacks of" is correct and usable in written English.
You can use it when discussing ways to mitigate negative aspects or disadvantages of a particular situation, method, or product.
Example: "By implementing this new strategy, we can avoid the drawbacks of our previous approach and enhance overall efficiency."
Alternatives: "eliminate the downsides of" or "prevent the negative effects of".
Founded in 1986, its mission is to discover and promote the upsides, and help avoid the drawbacks, of nanotechnology, artificial intelligence, biotechnology, and similar life-changing developments.
To maintain the advantages but to avoid the drawbacks of pulsing flow, a study has been set up to expand the pulsing flow regime.
To equip OIO with a mechanism to handle constraints and to avoid the drawbacks of typical techniques, a feasibility measure is used beside the objective function value to bias the search toward feasible regions.
The developed approach is evaluated against some of the previously used ranking approaches and the results provide experimental evidences on its ability to avoid the drawbacks of the ranking approaches.
Xarelto had been expected to be one of a handful of new drugs for atrial fibrillation that their makers hoped would avoid the drawbacks of warfarin, like interactions with other drugs and foods, requiring careful and frequent monitoring of the level of warfarin in the blood.
Meeting participants presented the results and experience of representative clinical trials of NA vaccines using a variety of alternative delivery devices, as well as a broader group of methods studied in animal models and at bench top, to improve upon the performance and/or avoid the drawbacks of conventional needle-syringe (N S) delivery.
To avoid the drawback of the (fixed) space-partitioned fuzzy controllers, a flexible spacial model design with fuzzy adaptive approach is introduced.
The results show that unbalanced function based MDR can avoid the drawback of common MDR in an unbalanced real data set.
In addition, our study was controlled against physiological saline solution and the products were injected randomly in the two hemifaces to avoid the drawback of inter-individual variations.
The results of this study suggest that anti-PLVAP Fab-TF may be used to treat HCC cases for which transcatheter arterial chemoembolization (TACE) is currently used and potentially avoid the drawback of high viscosity of chemoembolic emulsion for TACE to improve therapeutic outcome.
